Protection against malaria induced by chirally modified Plasmodium falciparum's MSP-1 42 pseudopeptides

José Manuel Lozano1, Fabiola Espejo, Ricardo Vera

  • 1Fundación Instituto de Inmunología de Colombia (FIDIC), Bogotá D.C., Colombia. jm_lozano@fidic.org.co

Insights

Modifying a malaria parasite peptide with D-amino acids and isoster bonds enhanced its immunogenicity and structural properties. This novel approach shows promise for developing effective subunit-based malaria vaccines against Plasmodium falciparum.

Area of Science:

  • Immunology
  • Structural Biology
  • Vaccine Development

Background:

  • The C-terminal portion of Plasmodium falciparum merozoite surface protein 1 (MSP-1) is crucial for erythrocyte invasion.
  • The MSP-1(1585) peptide, derived from MSP-1(42), exhibits poor immunogenicity and a stable alpha-helical structure.
  • Overcoming the immunological limitations of MSP-1(1585) is essential for developing effective malaria vaccines.

Purpose of the Study:

  • To assess the impact of alpha-carbon asymmetry on the host immune response.
  • To enhance the immunogenicity and structural properties of the MSP-1(1585) peptide.
  • To explore novel strategies for designing subunit-based malaria vaccines.

Main Methods:

  • Incorporation of single D-amino acids and psi-[CH(2)-NH] isoster bonds into the MSP-1(1585) peptide.
  • Analysis of immunogenicity and 3D-structure modifications.
  • Evaluation of specific binding to red blood cells (RBCs) and HLA alleles.
  • Immunization of animals with modified peptides and assessment of antibody responses and protection.

Main Results:

  • Site-directed chiral modifications, including D-substitutions and isoster bonds, enhanced specific binding to RBCs.
  • The modified peptide demonstrated high specificity for the HLA-DRB1*1101 allele.
  • Antibodies generated against D-analog pseudopeptides recognized native and recombinant MSP-1(42) and MSP-1(33) fragments.
  • Immunization with a specific D-analog analog induced protection and reduced parasitemia in Aotus monkeys.

Conclusions:

  • Peptide alpha-carbon chiral transformation is a viable strategy for structural modulation.
  • This approach offers a novel pathway for designing multi-component subunit-based malaria vaccines.
  • The study highlights the potential of D-amino acid incorporation for improving vaccine candidate efficacy.

Related Concept Videos

Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Symbiosis00:58

Symbiosis

Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
Diversity of Protists II01:27

Diversity of Protists II

Alveolates are a group of organisms recognized by the presence of alveoli, which are cytoplasmic sacs located beneath the cell membrane. While their function remains uncertain, alveoli may help regulate water balance by controlling how much water enters and leaves the cell. In dinoflagellates, these structures may serve as armor plates. There are three major types of alveolates: ciliates, which move using cilia; dinoflagellates, which use flagella for movement; and apicomplexans, which are...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...